Position in GSK
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$425,021
-$22,459 QoQ
Shares Held
8,108
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#509
of 1,033 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTH STAR ASSET MANAGEMENT INC holds $29,508,507 across 9 Drug Manufacturers - General names. GSK ranks #7 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,325 | $13,583,545 | |
| 2 | JNJ |
Johnson & Johnson
|
28,155 | $7,150,524 | |
| 3 | AMGN |
Amgen Inc
|
10,471 | $3,791,758 | |
| 4 | NVO |
Novo Nordisk A S
|
40,676 | $1,950,007 | |
| 5 | PFE |
Pfizer Inc
|
40,700 | $980,056 | |
| 6 | NVS |
Novartis AG
|
6,158 | $965,081 | |
| 7 | GSK |
GSK plc
This page
|
8,108 | $425,021 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
7,161 | $412,615 |
All Filings in GSK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $425,021 | 8,108 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $447,480 | 8,108 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $398,597 | 8,128 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||